Weidong Huang

Title: Weidong Huang: Innovator in Cancer Diagnostics

Introduction

Weidong Huang is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of cancer diagnostics, holding a total of 8 patents. His innovative work focuses on methods that enhance the detection and evaluation of cancerous cells.

Latest Patents

One of his latest patents is titled "Measuring esterase activity using fluorescent substrates as a way of evaluating cervical cancer." This invention provides methods for determining whether test cells in a sample are cancerous and whether lymphocytes are activated. The method measures the test cell's DNA ploidy and the cellular activity of an enzyme such as an esterase, which has altered expression in cancer cells. Esterase activity can be measured using fluorescent compounds like fluorescein diacetate. Another notable patent is the "Trabecular meshwork induced glucocorticoid response (TIGR) fusion protein." This invention relates to a glucocorticoid-induced protein, TIGR, produced by cells of the trabecular meshwork, which can be used to diagnose glaucoma. The TIGR protein, anti-TIGR antibodies, and TIGR encoding sequences provide a diagnostic for glaucoma and its related diseases.

Career Highlights

Weidong Huang has worked at the University of California, where he has contributed to various research projects and innovations. His work has been instrumental in advancing the understanding of cancer diagnostics and treatment.

Collaborations

Throughout his career, Huang has collaborated with notable individuals such as Thai D Nguyen and Jon R Polansky. These collaborations have further enriched his research and innovations in the field.

Conclusion

Weidong Huang's contributions to cancer diagnostics through his innovative patents highlight his role as a leading inventor in the medical field. His work continues to pave the way for advancements in cancer detection and treatment.